SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001558370-21-007070
Filing Date
2021-05-13
Accepted
2021-05-13 16:06:49
Documents
56
Period of Report
2021-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q armp-20210331x10q.htm 10-Q 827007
2 EX-31.1 armp-20210331ex31187b47d.htm EX-31.1 15592
3 EX-31.2 armp-20210331ex312979dcc.htm EX-31.2 15378
4 EX-32.1 armp-20210331ex32126f36c.htm EX-32.1 7925
5 EX-32.2 armp-20210331ex32291a4a3.htm EX-32.2 8105
6 GRAPHIC armp-20210331x10q001.jpg GRAPHIC 31130
  Complete submission text file 0001558370-21-007070.txt   3658293

Data Files

Seq Description Document Type Size
7 EX-101.INS armp-20210331.xml EX-101.INS 618679
8 EX-101.SCH armp-20210331.xsd EX-101.SCH 33930
9 EX-101.CAL armp-20210331_cal.xml EX-101.CAL 34991
10 EX-101.DEF armp-20210331_def.xml EX-101.DEF 112792
11 EX-101.LAB armp-20210331_lab.xml EX-101.LAB 272737
12 EX-101.PRE armp-20210331_pre.xml EX-101.PRE 240757
Mailing Address 4503 GLENCOE AVENUE MARINA DEL REY CA 90292
Business Address 4503 GLENCOE AVENUE MARINA DEL REY CA 90292 310-665-2928
Armata Pharmaceuticals, Inc. (Filer) CIK: 0000921114 (see all company filings)

IRS No.: 911549568 | State of Incorp.: WA | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-37544 | Film No.: 21919613
SIC: 2836 Biological Products, (No Diagnostic Substances)
Office of Life Sciences